Ulthera vs Thermage at a glance
| Topic | Ulthera | Thermage FLX |
|---|---|---|
| Technology | Micro-focused ultrasound with visualization (MFU-V) | Monopolar radiofrequency (RF) |
| Energy pattern | Rows of discrete thermal-coagulation points at selected nominal depths | Broader impedance-dependent heating under the treatment tip |
| During-treatment guidance | Real-time ultrasound images of dermal and subdermal tissue | Skin-contact monitoring, RF tuning, conductive cooling and vibration; no ultrasound image |
| Useful discussion | Mild-to-moderate laxity when depth-specific planning and imaging matter | Wrinkles, firmness and mild-to-moderate laxity when broader monopolar-RF heating is being considered |
| Does it restore lost volume? | No | No |
| Does it replace a facelift? | No | No |
| Package unit | Lines | Shots or pulses — not equivalent to Ulthera lines |
Regulatory note: US FDA clearance, Thai FDA registration and a clinic's marketing language are not interchangeable. Indications can differ by country and model. Verify the exact device and current Thai registration before treatment.
How the technologies differ
Ulthera: focused ultrasound plus imaging
Ulthera concentrates ultrasound into small thermal zones at nominal focal depths determined by the transducer. A treatment line contains multiple focused points. Its DeepSEE imaging is used to view tissue, check contact and help place energy away from bone. Imaging improves planning; it does not make every line identical or remove risk.
Depth labels such as 4.5 mm describe the transducer's nominal focus — they do not prove that every point lands in the SMAS. Facial layers vary by person and location, so anatomy and the live image still matter.
Thermage FLX: monopolar RF with surface cooling
Thermage sends RF energy between a disposable treatment tip and a return electrode. The system monitors contact and adjusts energy delivery across different tissue impedances while cooling protects the epidermis. This produces a broader heating pattern than focused ultrasound; it is not one sharply fixed treatment depth.
That difference is more useful than the common slogan “Ulthera is deep and Thermage is shallow.” Both treatments can affect more than one tissue level, and the clinically relevant pattern depends on the transducer or tip, energy, passes, area and individual anatomy.
Which concerns fit each option?
- Ulthera may enter the discussion when mild-to-moderate laxity under the chin, along the neck or around the brow is the concern and the doctor wants focal-depth planning with ultrasound visualization.
- Thermage may enter the discussion when wrinkles, skin firmness and early laxity are the main concerns and a doctor recommends broader monopolar-RF heating.
- Neither fixes every soft jawline. A double chin can reflect fat, skin laxity, chin projection, muscle or several causes together.
- Neither replaces missing volume. Hollow temples or cheeks may look worse if a tightening treatment is chosen for a volume problem.
- Neither reproduces surgery. Advanced tissue descent or excess skin needs a surgical opinion if a meaningful lift is the goal.
Age and brand popularity are poor selectors. The decision should start with the feature being treated, facial fat distribution, bone structure, skin quality, previous fillers or energy procedures and the operator's plan.
What does the comparison evidence show?
The most direct published comparison was a small, randomized split-face trial of 20 women aged 32–60 with mild-to-moderate laxity. It used the earlier Thermage CPT generation — not the current FLX — for monopolar RF on one side and MFU-V on the other. Both sides improved through six months, and the study found no statistically significant difference between technologies in standardized laxity ratings, satisfaction or adverse events.
That is useful evidence against declaring a universal winner, but it does not prove that CPT and FLX are clinically identical. Nor is a 20-person trial enough to predict an individual's result or prove that every current protocol is equivalent. Broader reviews support measurable improvement from MFU-V and monopolar RF in selected patients, while also showing varied devices, methods, follow-up periods and outcome scales.
Comfort, downtime and duration
Both procedures can hurt. Focused-ultrasound lines may feel sharp, hot or deeply aching; Thermage may feel like repeated heat pulses despite cooling and vibration. Pain varies with area, settings, anatomy and the person being treated, so “painless” should not be treated as a guarantee.
Planned downtime is often limited. Redness, swelling, tenderness or altered sensation can still occur, and low downtime does not mean low biological effect. Visible change usually develops gradually rather than appearing as a surgical-style lift on the day.
Do not rely on a fixed promise such as “one year” or “two years.” The small earlier-generation comparison followed patients for six months, while longer estimates come from different studies, protocols and marketing claims. Starting laxity, treatment plan, ageing and the way improvement is measured all affect durability.
Risks and contraindications
Ulthera: common reported effects include redness, swelling, pain and tenderness. Temporary numbness, tingling or nerve-related weakness can occur. Burns, welts, contour change and persistent symptoms are less common but require medical assessment.
Thermage: reported effects include pain, swelling, redness or blanching, bruising, altered sensation and pigment change. Blisters, burns, scarring, surface irregularities and nodules are possible. Thermage is contraindicated for people with a pacemaker, implantable cardioverter-defibrillator or another implanted electrical device.
Ulthera should not be used over open wounds, severe or cystic acne, or active or metallic implants in the treatment area. Both devices need extra review around previous fillers, implants, active skin disease and recent procedures. Pregnancy and breastfeeding are not situations for assuming elective treatment safety simply because the skin is not broken.
Why lines and shots do not match
An Ulthera line is a row of focused ultrasound points. A Thermage shot is an RF pulse delivered through a tip over an area. The numbers describe different devices, heat patterns and coverage plans, so 600 shots cannot be converted into 600 lines.
Ask what areas are covered, which transducers or tips will be used, how the plan changes across thin and thick tissue, what endpoint the operator is watching and what the proposed count leaves untreated. A large package number is not a treatment rationale.
Can Ulthera and Thermage be combined?
Some clinicians use focused ultrasound and monopolar RF in one overall plan because their energy patterns differ. That does not mean everyone needs both, or that same-day treatment is automatically safer or more effective. The direct evidence does not establish one universal combination, sequence or interval.
A combined plan should explain the separate job assigned to each device, total energy exposure, timing, previous fillers or other procedures and what additional benefit is realistically expected. “More collagen” is not a sufficient explanation.
Questions before booking
- Is my main issue laxity, wrinkles, fat, lost volume or bone structure?
- Which exact machine and model will be used, and is it currently registered in Thailand?
- Who examines me, plans the treatment and delivers the energy?
- For Ulthera, how will imaging change placement? For Thermage, which tip and passes are planned?
- Why does the proposed area and count fit my anatomy?
- What can this treatment not fix, and what outcome would count as disappointing?
- Which symptoms require a same-day call or medical examination?
The bottom line
Ulthera and Thermage are not interchangeable versions of the same treatment. Ulthera creates focused ultrasound points with tissue imaging; Thermage creates broader monopolar-RF heating with contact monitoring and cooling. Small direct evidence does not establish a universal winner. Choose by the diagnosed cause, exact device, treatment map and operator — not a depth slogan, package count or promised duration.